Other medical diagnostic panels will be developed in collaboration with laboratories to provide solutions suitable to their needs.
DendrisCHIP on respiratory viral infections is currently under study.
Oncograde : DendrisCHIP BC breast cancer recurrence prognosis
Breast cancer prognosis using original set of biomarkers and data analysis software based on fuzzy logic method. In oncology one of greatest subjects of study is how to better identify low risk recurrence population avoiding therefore chemotherapy and its secondary effects. From beginning of 2000’s new biomarkers have been selected by molecular methods in order to improve the tumor prognosis.Worldwide investment resources are dedicated to seek new efficient biomarkers able to better appreciate the risk of recurrence prognosis. Dendris is strongly involved in this research with clinical and scientific partners gathered in Oncograde R&D project. -See Publication-